rubbing shoulders with the right crowd.

http://medtechconference.com/2012-agenda/

9:15-10:00 Non-Conventional Sources of Financing

Moderator:
Thomas Letscher, Chairman – Oppenheimer Wolff & Donnelly LLP

Panelists:
Justin Canivet, Head, Business Development
Life Sciences & Global Diversified Industries – Toronto Stock Exchange & TSX Venture Exchange
Mark Maciejewski, Director – SHANGHAI Biomedical Enterprise LLC
Matthew Rizzo, Managing Director – OrbiMed Advisors
Dave Rosa, Chief Executive Officer – Sunshine Heart

************
Matthew Rizzo, Managing Director – OrbiMed Advisors
http://www.orbimed.com/history.htm

"With total assets under management of approximately $5 billion, OrbiMed ranks as the world's largest healthcare-dedicated investment firm."

+++++++++
Mark Maciejewski, Director – SHANGHAI Biomedical Enterprise LLC
http://www.prnewswire.com/news-releases/lonestar-heart-inc-names-andrew-j-coats-md-and-mark-maciejewski-to-its-board-of-directors-137953913.html

"Mark Maciejewski, 56, is president and chief executive officer of Sinnomedical, L.L.C., a China-based company creating strategic partnerships with U.S. companies to transfer new medical technologies to China. He also serves as senior vice president of international investments at the National Technology Enterprise Co. of the Kuwait Investment Authority."

"LoneStar Heart Inc. is developing cardiac restorative therapies for patients with heart failure that harness the heart's ability to repair itself. Based on its integrated cardiomechanical and biomolecular technologies, the privately held company is advanc­ing a broad portfolio of products to restore the failing heart's structure and function in collaboration with the Texas Heart Institute, the UTSW, and a global network of leading clinicians. These products include Algisyl-LVR™, cardiac stem-cell modulators, and cellular and genetic therapies delivered as stand-alone treatments, or in combination with the company's proprietary biopolymer matrix system."

http://www.lonestarheartinc.com/

Interesting products.
Would, on the surface appear to be a strong symbiotic relationship between LoneStar Heart and Sunshine Heart

Sunshine Heart is definitely rubbing shoulders in the right circles?

The question is "Is Dave there on past performance and contacts or has his name been put forward on some "deal" we don't know about yet?"
I find it hard to believe he would be on that panel if the organisers thought he was CEO of a B grade looser company. Maybe he is an example of a company trying to raise funds, maybe he is the success story?

Rollon the Bots somebodies keen on us.

===============

Caution Tea Leaf reading is an inexact science.